Product Details for ANDA 076059
LISINOPRIL (LISINOPRIL)
2.5MG
Marketing Status: Prescription
5MG
Marketing Status: Prescription
10MG
Marketing Status: Prescription
20MG
Marketing Status: Prescription
30MG
Marketing Status: Prescription
40MG
Marketing Status: Prescription
2.5MG
Marketing Status: Prescription
Active Ingredient: LISINOPRIL
Proprietary Name: LISINOPRIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076059
Product Number: 001
Approval Date: Jul 1, 2002
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status: Prescription
Patent and Exclusivity Information
LISINOPRIL (LISINOPRIL)
Proprietary Name: LISINOPRIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076059
Product Number: 001
Approval Date: Jul 1, 2002
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status: Prescription
Patent and Exclusivity Information
5MG
Marketing Status: Prescription
Active Ingredient: LISINOPRIL
Proprietary Name: LISINOPRIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076059
Product Number: 002
Approval Date: Jul 1, 2002
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status: Prescription
Patent and Exclusivity Information
LISINOPRIL (LISINOPRIL)
Proprietary Name: LISINOPRIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076059
Product Number: 002
Approval Date: Jul 1, 2002
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status: Prescription
Patent and Exclusivity Information
10MG
Marketing Status: Prescription
Active Ingredient: LISINOPRIL
Proprietary Name: LISINOPRIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076059
Product Number: 003
Approval Date: Jul 1, 2002
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status: Prescription
Patent and Exclusivity Information
LISINOPRIL (LISINOPRIL)
Proprietary Name: LISINOPRIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076059
Product Number: 003
Approval Date: Jul 1, 2002
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status: Prescription
Patent and Exclusivity Information
20MG
Marketing Status: Prescription
Active Ingredient: LISINOPRIL
Proprietary Name: LISINOPRIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 20MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076059
Product Number: 004
Approval Date: Jul 1, 2002
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status: Prescription
Patent and Exclusivity Information
LISINOPRIL (LISINOPRIL)
Proprietary Name: LISINOPRIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 20MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076059
Product Number: 004
Approval Date: Jul 1, 2002
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status: Prescription
Patent and Exclusivity Information
30MG
Marketing Status: Prescription
Active Ingredient: LISINOPRIL
Proprietary Name: LISINOPRIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 30MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076059
Product Number: 005
Approval Date: Jul 1, 2002
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status: Prescription
Patent and Exclusivity Information
LISINOPRIL (LISINOPRIL)
Proprietary Name: LISINOPRIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 30MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076059
Product Number: 005
Approval Date: Jul 1, 2002
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status: Prescription
Patent and Exclusivity Information
40MG
Marketing Status: Prescription
Active Ingredient: LISINOPRIL
Proprietary Name: LISINOPRIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 40MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076059
Product Number: 006
Approval Date: Jul 1, 2002
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: LISINOPRIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 40MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076059
Product Number: 006
Approval Date: Jul 1, 2002
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status: Prescription
Patent and Exclusivity Information